Register for free to
view the full innovation profile.
FLX is a clinically proven APP that prevents and treats musculoskeletal problems. Based on an over 4000 patient dataset it is clinically proven to reduce incidence by 65%.
About
FLX is a native mobile APP (Android and iOS) that uses clinically validated algorithms to help prevent musculoskeletal disease and injury; treat pain; and support healthy movement. FLX uses advanced biomechanics understanding and tailored physiotherapy exercises to deliver its efficacy. FLX has 3 main claims areas: 1. Reduces the risk of musculoskeletal disease, pain and injury (reduces risk of musculoskeletal disease by up to 60%) 2. Treats pain (causes up to 70% reduction in pain, 10% is considered clinically relevant) 3. Supports healthy movement and function (increases flexibility 149%, mobility 42%, and function by 95%) Musculoskeletal disease is a major source of health issues and contributes enormously to employee wellbeing, being a major cause of absenteeism. COVID-19 has forced people to work from home in non-optimised workstations that increase the risk musculoskeletal problems, FLX is an ideal tool to help prevent this risk as it can be done at home quickly without the need for any health care professional time and is clinically proven to reduce risk. FLX uses algorithms developed in a patient group of 4000 subjects that allow us to personalise our programmes to the users needs. We are the only digital product that can do this without the review or involvement of a physiotherapist, it is all done algorithmically; we are the only product that PREVENTS rather than just treats. Our IP is 'know-how' that built the algorithms this is secret and is protected in this way. The code that we have built is protected by copyright. The IP is locked into the clinical knowledge of 4000 patients. We have six clinical studies that support our product: F0001 = 4000 patient study of biomechanics that forms the basis of the algorithms. F0002 = pilot study to confirm the efficacy of the algorithms in preventing musculoskeletal disease and pain; and supporting movement (n=237) F0003 = confirmatory efficacy study (n = 61) F0004 = pain study in health club setting (n = 81) F0005 = pain study in NHS patients (n = 282) F0006 = validation of algorithms in physiotherapy triage (n = 118)
Key Benefits
Treats and PREVENTS body pain. 1. Reduces the risk of musculoskeletal disease, pain and injury (reduces risk of musculoskeletal disease by up to 60%) 2. Treats pain (causes up to 70% reduction in pain, 10% is considered clinically relevant) 3. Supports healthy movement and function (increases flexibility 149%, mobility 42%, and function by 95%) CAN HELP PROTECT THE MUSCULOSKELETAL HEALTH OF EMPLOYEES WORKING FROM HOME.
Applications
Maintainenace of musculoskeletal health when working from home. Health and safety. Prevention of biomechanical problems and musculoskeletal disease. Corporate Wellbeing; adjunct to pharmaceuticals; and or Private Health Insurance.